Nitric Oxide Innovations LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin
Phase 1
Terminated
- Conditions
- COVID-19
- Interventions
- Drug: Nitric Oxide lozenges, 30 mgDrug: Placebo
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Nitric Oxide Innovations LLC
- Target Recruit Count
- 524
- Registration Number
- NCT04601077
- Locations
- 🇺🇸
American Institute of Therapeutics, Lake Bluff, Illinois, United States
News
No news found